Jan 14, 2011 - 1:53 am
Here are the latest published results for CyberKnife treatments which will help guys with localized new PCa cases (low-risk prostate cancer patients) when deciding on a treatment option. The biochemical progression-free survival at 5 years was 93%. The short term side effects were resolved within 1-3 months from treatment completion.
I wish the best to all in our bumpy road.